117 related articles for article (PubMed ID: 38625716)
1. Prognostic effect of masked morning hypertension in Chinese inpatients with non-dialysis chronic kidney disease: A multi-center retrospective study.
Lin L; Jiang X; Liu L; Wu J; Yu T; Wei Y; Li M; Peng H; Wang C
Am J Hypertens; 2024 Apr; ():. PubMed ID: 38625716
[TBL] [Abstract][Full Text] [Related]
2. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
[TBL] [Abstract][Full Text] [Related]
3. Masked morning hypertension correlated with target organ damage in non-dialysis patients with chronic kidney disease.
Li X; Lian R; Zhu Y; Ke J; Li M; Wang C; Lou T
J Hypertens; 2020 Sep; 38(9):1794-1801. PubMed ID: 32694329
[TBL] [Abstract][Full Text] [Related]
4. Association of morning hypertension with chronic kidney disease progression and cardiovascular events in patients with chronic kidney disease and hypertension.
Liu X; Li F; Zheng Z; Li G; Zhou H; Zhang T; Tang Y; Qin W
Nutr Metab Cardiovasc Dis; 2022 Apr; 32(4):965-972. PubMed ID: 35172934
[TBL] [Abstract][Full Text] [Related]
5. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
[TBL] [Abstract][Full Text] [Related]
6. White-coat and masked hypertension diagnoses in chronic kidney disease patients.
Pereira H; Bonilha A; Barretti P; Silva R; Burgugi V; Dos Santos V; Cuadrado L
J Clin Hypertens (Greenwich); 2020 Jul; 22(7):1202-1207. PubMed ID: 32608106
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study.
Fujiwara T; Hoshide S; Kanegae H; Kario K
Hypertension; 2020 Jul; 76(1):259-266. PubMed ID: 32520613
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S
Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751
[TBL] [Abstract][Full Text] [Related]
9. Different effects of morning and nocturnal hypertension on target organ damage in chronic kidney disease.
Li X; Ke J; Chen X; Yin M; Lou T; Zhang J; Peng H; Wang C
J Clin Hypertens (Greenwich); 2021 May; 23(5):1051-1059. PubMed ID: 33682307
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease.
Wang C; Li Y; Zhang J; Ye Z; Zhang Q; Ma X; Peng H; Lou T
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792646
[TBL] [Abstract][Full Text] [Related]
11. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
[TBL] [Abstract][Full Text] [Related]
12. Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.
Fu X; Ren H; Xie J; Wang W; Li Y; Gao P; Chen N
JAMA Netw Open; 2022 May; 5(5):e2214460. PubMed ID: 35616936
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Rahman M; Wang X; Bundy JD; Charleston J; Cohen D; Cohen J; Drawz PE; Ghazi L; Horowitz E; Lash JP; Schrauben S; Weir MR; Xie D; Townsend RR;
J Am Soc Nephrol; 2020 Nov; 31(11):2609-2621. PubMed ID: 32973085
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum phosphorus and mortality in non-dialysis chronic kidney disease patients: evidence from NHANES 2001-2018.
Fan Z; Li R; Pan M; Jiang Y; Li Y; Liu L; Li Y
BMC Nephrol; 2024 Mar; 25(1):89. PubMed ID: 38448815
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S
BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030
[TBL] [Abstract][Full Text] [Related]
16. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants for chronic kidney disease.
Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940
[TBL] [Abstract][Full Text] [Related]
18. Effects of bariatric surgery on kidney diseases, cardiovascular diseases, mortality and severe hypoglycaemia among patients with Type 2 diabetes mellitus.
Wong CKH; Wu T; Wong SKH; Law BTT; Grieve E; Ng EKW; Wu O; Lam CLK
Nephrol Dial Transplant; 2021 Jul; 36(8):1440-1451. PubMed ID: 32591819
[TBL] [Abstract][Full Text] [Related]
19. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
